QSI vs. TRNS, CTKB, SENS, EYPT, LAB, ALNT, AEHR, QTRX, MASS, and FEIM
Should you be buying Quantum-Si stock or one of its competitors? The main competitors of Quantum-Si include Transcat (TRNS), Cytek Biosciences (CTKB), Senseonics (SENS), EyePoint Pharmaceuticals (EYPT), Standard BioTools (LAB), Allient (ALNT), Aehr Test Systems (AEHR), Quanterix (QTRX), 908 Devices (MASS), and Frequency Electronics (FEIM). These companies are all part of the "measuring and control equipment" industry.
Quantum-Si vs.
Transcat (NASDAQ:TRNS) and Quantum-Si (NASDAQ:QSI) are both small-cap computer and technology companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, community ranking, valuation, profitability, dividends, risk, media sentiment and institutional ownership.
Transcat has a net margin of 6.22% compared to Quantum-Si's net margin of -3,968.84%. Transcat's return on equity of 7.23% beat Quantum-Si's return on equity.
In the previous week, Transcat had 6 more articles in the media than Quantum-Si. MarketBeat recorded 9 mentions for Transcat and 3 mentions for Quantum-Si. Transcat's average media sentiment score of 1.60 beat Quantum-Si's score of 0.91 indicating that Transcat is being referred to more favorably in the media.
Transcat has a beta of 0.67, indicating that its share price is 33% less volatile than the S&P 500. Comparatively, Quantum-Si has a beta of 2.71, indicating that its share price is 171% more volatile than the S&P 500.
Transcat has higher revenue and earnings than Quantum-Si. Quantum-Si is trading at a lower price-to-earnings ratio than Transcat, indicating that it is currently the more affordable of the two stocks.
Transcat received 202 more outperform votes than Quantum-Si when rated by MarketBeat users. However, 69.23% of users gave Quantum-Si an outperform vote while only 66.14% of users gave Transcat an outperform vote.
98.3% of Transcat shares are held by institutional investors. Comparatively, 39.9% of Quantum-Si shares are held by institutional investors. 2.3% of Transcat shares are held by company insiders. Comparatively, 30.0% of Quantum-Si shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Transcat currently has a consensus price target of $111.50, indicating a potential upside of 40.55%. Quantum-Si has a consensus price target of $3.48, indicating a potential upside of 204.82%. Given Quantum-Si's stronger consensus rating and higher possible upside, analysts clearly believe Quantum-Si is more favorable than Transcat.
Summary
Transcat beats Quantum-Si on 11 of the 17 factors compared between the two stocks.
Get Quantum-Si News Delivered to You Automatically
Sign up to receive the latest news and ratings for QSI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Quantum-Si Competitors List
Related Companies and Tools
This page (NASDAQ:QSI) was last updated on 5/1/2025 by MarketBeat.com Staff
Buy QSI Stock Free QSI Stock Alerts